KCM
SRPT icon

Kornitzer Capital Management’s Sarepta Therapeutics SRPT Stock Holding History

Kornitzer Capital Management’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-139,145
Closed -$5.37M – 472
2015
Q4 		$5.37M Buy
139,145
+9,765
+8% +$317K 0.09% 247
2015
Q3 		$4.15M Sell
129,380
-30,665
-19% -$1.04M 0.07% 263
2015
Q2 		$4.87M Sell
160,045
-455
-0.3% -$9.3K 0.07% 267
2015
Q1 		$2.13M Hold
160,500
– – 0.03% 321
2014
Q4 		$2.32M Sell
160,500
-487,980
-75% -$8.26M 0.03% 309
2014
Q3 		$13.7M Buy
648,480
+3,505
+0.5% +$79.1K 0.16% 156
2014
Q2 		$19.2M Buy
644,975
+98,175
+18% +$3.1M 0.21% 133
2014
Q1 		$13.1M Sell
546,800
-65,275
-11% -$1.66M 0.14% 170
2013
Q4 		$12.5M Buy
612,075
+47,900
+8% +$1.42M 0.13% 177
2013
Q3 		$26.6M Buy
564,175
+495,975
+727% +$19.1M 0.31% 99
2013
Q2 		$2.59M Buy
+68,200
New +$2.44M 0.03% 253

Other funds holding SRPT

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return

Kornitzer Capital Management's SRPT Position: Q1 2016 in Review

Kornitzer Capital Management sold out of Sarepta Therapeutics (SRPT) in Q1 2016, closing a stake of 139,145 shares — an estimated $5.37M sold.

Kornitzer Capital Management first reported a position in SRPT in Q2 2013 and held it in 11 quarters. The position peaked at $26.6M in Q3 2013. 132 funds tracked by Wall St. Rank hold SRPT as of Q1 2016.

  • Kornitzer Capital Management reported no remaining Sarepta Therapeutics position as of Q1 2016 after selling out during the quarter.
  • Kornitzer Capital Management sold 139,145 Sarepta Therapeutics shares in Q1 2016, an estimated $5.37M.
  • Kornitzer Capital Management first reported a position in Sarepta Therapeutics in Q2 2013 and held it in 11 quarters.
  • Kornitzer Capital Management's Sarepta Therapeutics position peaked at $26.6M in Q3 2013.
  • 132 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q1 2016.

Based on Kornitzer Capital Management's 13F filing for Q1 2016, filed 2 May 2016.